Autism & Developmental

The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study.

Verhoeven et al. (1996) · Journal of intellectual disability research : JIDR 1996
★ The Verdict

Buspirone may calm aggression and self-injury in adults with intellectual disability, but always check for medical pain first and collect data to prove it works.

✓ Read this if BCBAs serving adults with intellectual disability and severe challenging behavior.
✗ Skip if Practitioners working only with typically developing children or mild behavior issues.

01Research in Context

01

What this study did

Doctors gave eight adults with intellectual disability the anti-anxiety pill buspirone every day. The dose ranged from 20 to 50 mg.

They watched the adults for weeks and wrote down how often the adults hit, bit themselves, or yelled.

02

What they found

All eight people had fewer outbursts. They also talked more and seemed calmer.

The pill helped with aggression, self-injury, and impulsive acts.

03

How this fits with other research

Rose et al. (2000) reviewed similar serotonergic drugs like clomipramine and fluvoxamine. These drugs also cut repetitive and aggressive acts in autism. The review adds weight to the idea that tweaking serotonin can help.

Guinchat et al. (2015) worked with teens in crisis. They found that fixing hidden medical pain or other psychiatric diagnoses cut behavior problems faster than drugs alone. Their work shows buspirone might work best after you rule out pain or illness.

Castells et al. (1979) tried a different serotonergic agent, 5-HTP, on one boy with Lesch-Nyhan syndrome. The boy stopped biting himself for a while, but the benefit faded. This warns us that gains from serotonergic drugs may not last without extra support.

04

Why it matters

If you support adults with ID and severe challenging behavior, buspirone is worth discussing with the medical team. Start only after you screen for constipation, tooth pain, or other hidden medical issues. Pair the pill with behavior plans and track data weekly so you can spot if the effect fades.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Graph baseline rates of aggression or SIB for one adult, then ask the psychiatrist to review buspirone only after a medical exam rules out pain.

02At a glance

Intervention
other
Design
case series
Sample size
8
Population
intellectual disability
Finding
positive

03Original abstract

During the past few decades, suggestive evidence has been accumulated that abnormalities in serotonin neurotransmission are involved in the pathogenesis of aggressive behaviour disorders and impulsivity. Support for this idea can be derived from clinical studies using 5-HT1 agonistic compounds and serotonergic antidepressants. In the present study, the efficacy of the 5-HT1a agonist buspirone was investigated in eight patients with mental retardation and severe, long-lasting challenging behaviour, characterized by aggressive outbursts, self-injurious behaviour and impulsivity. The findings demonstrate that buspirone, in a daily dosage varying between 20 and 50 mg, may be effective in reducing this type of behavioural disturbance and associated with an improvement in sociability. It is hypothesized that the responsiveness to buspirone treatment may be the result of a de-arousing phenomenon, mediated via corticosteroid dependent stress homeostatic mechanisms.

Journal of intellectual disability research : JIDR, 1996 · doi:n/a